Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
MLN8237 is an inhibitor of Aurora A kinase (IC50 = 1 nM).1 It is selective for Aurora A over Aurora B kinase (IC50 = 396.5 nM).2 MLN8237 (50 nM) induces cell cycle arrest at the G2/M phase and chromosomal misalignment in HCT116 colon cancer cells. It inhibits tumor growth in a Calu-6 non-small cell lung cancer (NSCLC) mouse xenograft model when administered at a dose of 20 mg/kg.1
WARNING This product is not for human or veterinary use.
1. MLN8054 and alisertib (MLN8237): Discovery of selective oral Aurora A inhibitors. ACS Med. Chem. Lett. 6(6), 630-634 (2015).
2. Characterization of alisertib (MLN8237), an investigational small-
Phosphorylation and chromatin tethering prevent cGAS activation during mitosis. Science (2021).